Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Cancer Cachexia Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025

Table of Content

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives

2. Assumptions and Research Methodology

3. Executive Summary: Global Cancer Cachexia Market 

4. Market Overview
     4.1. Introduction
            4.1.1. Therapeutics Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunities
     4.5. Global Cancer Cachexia Market Analysis and Forecasts, 2014-2024
            4.5.1. Market Revenue Projections (US$ Mn)
     4.6. Cancer Cachexia Market - Global Supply Demand Scenario
     4.7. Porter’s Five Force Analysis
     4.8. Regulatory Scenario
     4.9. Cancer Cachexia – Incidence Rate
     4.10. Cancer Cachexia – Therapeutic Approach
     4.11. Cancer Cachexia Market: Pipeline Analysis
            4.11.1. Phase III drugs (Forecast from approval year to 2024)
            4.11.2. Phase I and Phase II drugs (Qualitative Information)

5. Global Cancer Cachexia Market Analysis and Forecasts, By Therapeutics 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast by Therapeutics, 2015–2025
            5.4.1. Progestogens
            5.4.2. Corticosteroids
            5.4.3. Combination therapies
     5.5. Market Attractiveness by Therapeutics
 
6. Global Cancer Cachexia Market Analysis and Forecasts, By Mechanism of action 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value Forecast by Mechanism of action, 2015–2025
            6.4.1. Appetite Stimulators
            6.4.2. Weight loss stabilizers
            6.4.3. Others
     6.5. Market Attractiveness by Mechanism of action 

7. Global Cancer Cachexia Market Analysis and Forecasts, By Distribution Channels 
     7.1. Introduction & Definition
     7.3. Key Trends
     7.4. Market Value Forecast by Distribution Channels, 2015–2025
            7.4.1. Hospital Stores
            7.4.2. Retails Pharmacy Store
            7.4.3. Online Pharmacy
     7.5. Market Attractiveness by Distribution Channels 

8. Global Cancer Cachexia Market Analysis and Forecasts, By Region
     8.1. Key Findings
     8.2. Policies and Regulations
     8.3. Market Value Forecast by Region
            8.3.1. North America 
            8.3.2. Europe 
            8.3.3. Asia Pacific 
            8.3.4. Latin America 
            8.3.5. Middle East and Africa
     8.4. Market Attractiveness by Country/Region

9. North America Cancer Cachexia Market Analysis and Forecast
     9.1. Introduction
            9.1.2. Policies and Regulations
            9.1.3. Key Trends
     9.2. Market Value Forecast by Therapeutics, 2015–2025
            9.2.1. Progestogens
            9.2.2. Corticosteroids
            9.2.3. Combination therapies
     9.3. Market Value Forecast by Mechanism of action, 2015–2025
            9.3.1. Appetite Stimulators
            9.3.2. Weight loss stabilizers
            9.3.3. Others
     9.4. Market Value Forecast by Distribution Channels, 
            9.4.1. Hospital Stores
            9.4.2. Retails Pharmacy Store
            9.4.3. Online Pharmacy
     9.5. Market Value Forecast by Country, 2015–2025
            9.5.1. U.S.
            9.5.2. Canada
     9.6. Market Attractiveness Analysis 
            9.6.1. By Therapeutics 
            9.6.2. By Mechanism of action 
            9.6.3. By Distribution Channels 
            9.6.4. By Country

10. Europe Cancer Cachexia Market Analysis and Forecast
     10.1. Introduction
            10.1.2. Policies and Regulations
            10.1.3. Key Trends
     10.2. Market Value Forecast by Therapeutics, 2015–2025
            10.2.1. Progestogens
            10.2.2. Corticosteroids
            10.2.3. Combination therapies
     10.3. Market Value Forecast by Mechanism of action, 2015–2025
            10.3.1. Appetite Stimulators
            10.3.2. Weight loss stabilizers
            10.3.3. Others
     10.4. Market Value Forecast by Distribution Channels, 
            10.4.1. Hospital Stores
            10.4.2. Retails Pharmacy Store
            10.4.3. Online Pharmacy
     10.5. Market Value Forecast by Country, 2015–2025
            10.5.1. U.K.
            10.5.2. Germany
            10.5.3. France
            10.5.4. Italy
            10.5.5. Spain
            10.5.6. Russia
            10.5.7. Rest of Europe
     10.6. Market Attractiveness Analysis 
            10.6.1. By Therapeutics 
            10.6.2. By Mechanism of action 
            10.6.3. By Distribution Channels 
            10.6.4. By Country

11. Asia-Pacific Cancer Cachexia Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Policies and Regulations
            11.1.2. Key Trends
     11.2. Market Value Forecast by Therapeutics, 2015–2025
            11.2.1. Progestogens
            11.2.2. Corticosteroids
            11.2.3. Combination therapies
     11.3. Market Value Forecast by Mechanism of action, 2015–2025
            11.3.1. Appetite Stimulators
            11.3.2. Weight loss stabilizers
            11.3.3. Others
     11.4. Market Value Forecast by Distribution Channels, 
            11.4.1. Hospital Stores
            11.4.2. Retails Pharmacy Store
            11.4.3. Online Pharmacy
     11.5. Market Value Forecast by Country, 2015–2025
            11.5.1. India
            11.5.2. China
            11.5.3. Japan
            11.5.4. Australia & New Zealand
            11.5.5. Rest of Asia-Pacific
     11.6. Market Attractiveness Analysis 
            11.6.1. By Therapeutics 
            11.6.2. By Mechanism of action 
            11.6.3. By Distribution Channels 
            11.6.4. By Country

12. Latin America Cancer Cachexia Market Analysis and Forecast
     12.1. Introduction
            12.1.2. Policies and Regulations
            12.1.3. Key Trends
     12.2. Market Value Forecast by Therapeutics, 2015–2025
            12.2.1. Progestogens
            12.2.2. Corticosteroids
            12.2.3. Combination therapies
     12.3. Market Value Forecast by Mechanism of action, 2015–2025
            12.3.1. Appetite Stimulators
            12.3.2. Weight loss stabilizers
            12.3.3. Others
     12.4. Market Value Forecast by Distribution Channels, 
            12.4.1. Hospital Stores
            12.4.2. Retails Pharmacy Store
            12.4.3. Online Pharmacy
     12.5. Market Value Forecast by Country, 2015–2025
            12.5.1. Brazil
            12.5.2. Mexico
            12.5.3. Rest of Latin America
     12.6. Market Attractiveness Analysis 
            12.6.1. By Therapeutics 
            12.6.2. By Mechanism of action 
            12.6.3. By Distribution Channels 
            12.6.4. By Country

13. Middle East and Africa Cancer Cachexia Market Analysis and Forecast
     13.1. Introduction
            13.1.2. Policies and Regulations
            13.1.3. Key Trends
     13.2. Market Value Forecast by Therapeutics, 2015–2025
            13.2.1. Progestogens
            13.2.2. Corticosteroids
            13.2.3. Combination therapies
            13.2.4. Others
     13.3. Market Value Forecast by Mechanism of action, 2015–2025
            13.3.1. Appetite Stimulators
            13.3.2. Weight loss stabilizers
            13.3.3. Others
     13.4. Market Value Forecast by Distribution Channels, 
            13.4.1. Hospital Stores
            13.4.2. Retails Pharmacy Store
            13.4.3. Online Pharmacy
     13.5. Market Value Forecast by Country, 2015–2025
            13.5.1. South Africa
            13.5.2. GCC Countries
            13.5.3. Rest of Middle East and Africa
     13.6. Market Attractiveness Analysis 
            13.6.1. By Therapeutics 
            13.6.2. By Mechanism of action 
            13.6.3. By Distribution Channels 
            13.6.4. By Country

14. Competition Landscape
     14.1. Market Competition Analysis by Company (2016)
     14.2. Company Profiles
            14.2.1. Æterna Zentaris Inc.
                      14.2.1.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.1.2. Financials
                      14.2.1.3. Recent Development
                      14.2.1.4. Strategy
            14.2.2. Alder BioPharmaceuticals Inc.
                      14.2.2.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.2.2. Financials
                      14.2.2.3. Recent Development
                      14.2.2.4. Strategy
            14.2.3. Aphios Corporation
                      14.2.3.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.3.2. Financials
                      14.2.3.3. Recent Development
                      14.2.3.4. Strategy
            14.2.4. Eli Lilly and Company
                      14.2.4.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.4.2. Financials
                      14.2.4.3. Recent Development
                      14.2.4.4. Strategy
            14.2.5. GTx, Inc.
                      14.2.5.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.5.2. Financials
                      14.2.5.3. Recent Development
                      14.2.5.4. Strategy
            14.2.6. Helsinn Group
                      14.2.6.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.6.2. Financials
                      14.2.6.3. Recent Development
                      14.2.6.4. Strategy
            14.2.7. Merck & Co., Inc.
                      14.2.7.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.7.2. Financials
                      14.2.7.3. Recent Development
                      14.2.7.4. Strategy
            14.2.8. Novartis AG
                      14.2.8.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.8.2. Financials
                      14.2.8.3. Recent Development
                      14.2.8.4. Strategy
            14.2.9. Bristol-Myers Squibb Company
                      14.2.9.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.9.2. Financials
                      14.2.9.3. Recent Development
                      14.2.9.4. Strategy
            14.2.10. XBiotech, Inc.
                      14.2.10.1. Overview (HQ, Employee Strength, Business Segments)
                      14.2.10.2. Financials
                      14.2.10.3. Recent Development
                      14.2.10.4. Strategy

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote